Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Acupuncture does not work and has no place in science-based medicine.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.

Molecular oncology·2025

Same author

Label-efficient computational tumour infiltrating lymphocyte assessment in breast cancer (ECTIL): multicentre validation in 2340 patients with breast cancer.

The Lancet. Digital health·2025

Same author

A quality framework for cryopreserved rodent disease models: INFRAFRONTIER quality principles in EMMA archiving and distribution.

Mammalian genome : official journal of the International Mammalian Genome Society·2025

Same author

European cancer research requires renewed urgency.

Nature cancer·2025

Same author

Zincore, an atypical coregulator, binds zinc finger transcription factors to control gene expression.

Science (New York, N.Y.)·2025

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

A conditional mouse model for malignant mesothelioma.

Johan Jongsma¹, Erwin van Montfort, Marc Vooijs

¹Department of Molecular Genetics, Cancer Genomics Centre, Centre for Biomedical Genetics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

|March 11, 2008

Summary

This summary is machine-generated.

Loss of Neurofibromatosis type 2 (NF2) and RB/P53 pathway genetic lesions contribute to malignant mesothelioma. Ink4a loss significantly worsens outcomes in mouse models, highlighting its role in this aggressive cancer.

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Related Experiment Videos

Last Updated: Jul 6, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Area of Science:

Oncology
Cancer Biology
Genetics

Background:

Malignant mesothelioma is a rare but aggressive cancer.
Loss of Neurofibromatosis type 2 (NF2) and genetic alterations in RB and P53 pathways are implicated in its development.
Understanding the genetic drivers is crucial for developing effective treatments.

Purpose of the Study:

To investigate the role of NF2, RB, and P53 pathway alterations in a murine model of malignant mesothelioma.
To compare the impact of different genetic lesions on mesothelioma development and progression.
To assess the contribution of Ink4a loss to tumor aggressiveness and patient survival.

Main Methods:

Creation of conditional knockout mouse models with specific genetic lesions (Nf2;Ink4a/Arf and Nf2;p53).
Induction of genetic alterations in the mesothelial lining of the thoracic cavity.
Monitoring tumor development, survival rates, and invasiveness in the mouse models.

Main Results:

Mesothelioma developed with high incidence in both Nf2;Ink4a/Arf and Nf2;p53 conditional knockout mice.
Murine mesothelioma models closely recapitulated human malignant mesothelioma characteristics.
Conditional Nf2;Ink4a/Arf mice exhibited increased pleural invasion compared to Nf2;p53 mice.
Loss of Ink4a in Nf2;p53 mice significantly reduced survival and increased tumor invasiveness.

Conclusions:

NF2 loss, combined with RB/P53 pathway inactivation, can induce malignant mesothelioma in mice.
Ink4a loss plays a critical role in promoting mesothelioma aggressiveness and poor clinical outcomes.
These findings provide valuable insights into mesothelioma pathogenesis and potential therapeutic targets.